Kewaunee Scientific Corporation (KEQU)
Official siteCONSUMER CYCLICAL • FURNISHINGS, FIXTURES & APPLIANCES • NASDAQ
Market Cap: $103.36M
Last updated: Nov 17, 2026 at 3:04 AM ET
Kewaunee Scientific Corporation (KEQU) Financials: Revenue, Profit and Cash Flow
Kewaunee Scientific reported revenue of $282.00M for the fiscal year ended Apr 30, 2026, up 17.3% from the year before. That year, net income was $10.46M with a net margin of 3.7%, operating cash flow was $18.63M and free cash flow was $14.70M. The quarter ended Jul 31, 2026 had revenue of $66.32M and net income of $1.84M.
Revenue and Margins
The operating margin was 5.9% in the fiscal year ended Apr 2026. Over the 9 years to Apr 2026, revenue grew from $138.56M, a compound annual rate of 8.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Apr 2026 | $282.00M | +17.3% | 28.5% | 5.9% | 3.7% |
| Apr 2025 | $240.47M | +18.0% | 28.6% | 7.4% | 4.8% |
| Apr 2024 | $203.75M | -7.2% | 25.5% | 9.0% | 9.4% |
| Apr 2023 | $219.49M | +30.0% | 16.2% | 2.4% | 0.6% |
| Apr 2022 | $168.87M | +14.5% | 14.3% | -1.5% | -3.6% |
| Apr 2021 | $147.47M | 0.0% | 16.3% | -0.9% | -2.4% |
| Apr 2020 | $147.54M | +0.7% | 15.9% | -1.6% | -3.1% |
| Apr 2019 | $146.55M | -7.3% | 17.3% | 1.4% | 1.2% |
| Apr 2018 | $158.05M | +14.1% | 20.3% | 6.3% | 3.5% |
| Apr 2017 | $138.56M | N/A | 19.2% | 4.7% | 3.3% |
Income Statement
In the fiscal year ended Apr 2026, net income fell 9.7% from the year before. In the quarter ended Jul 2026, net income fell 41.8% from the same quarter a year earlier.
Annual
| Line item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.00M | $240.47M | $203.75M | $219.49M | $168.87M | $147.47M | $147.54M | $146.55M | $158.05M | $138.56M |
| Cost of revenue | $201.56M | $171.62M | $151.70M | $183.91M | $144.65M | $123.48M | $124.11M | $121.23M | $125.89M | $111.95M |
| Gross profit | $80.44M | $68.86M | $52.05M | $35.59M | $24.22M | $23.99M | $23.43M | $25.32M | $32.16M | $26.61M |
| Operating income | $16.71M | $17.76M | $18.28M | $5.36M | -$2.61M | -$1.32M | -$2.35M | $2.11M | $9.92M | $6.54M |
| Net income | $10.46M | $11.58M | $19.06M | $1.36M | -$6.00M | -$3.61M | -$4.62M | $1.69M | $5.46M | $4.62M |
| EBITDA | $24.44M | $22.98M | N/A | $9.17M | $916.00K | $459.00K | $281.00K | $5.07M | $12.68M | $9.74M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66.32M | $71.40M | $69.40M | $70.10M | $71.10M | $77.15M | $67.17M | $47.76M | $48.39M | $56.70M | $46.78M | $50.44M |
| Gross profit | $19.64M | $21.25M | $18.55M | $19.72M | $20.93M | $24.04M | $18.38M | $13.95M | $12.49M | $14.64M | $12.03M | $13.47M |
| Operating income | $3.16M | $5.22M | $2.58M | $4.11M | $4.81M | $8.50M | $2.25M | $4.43M | $2.58M | $5.56M | $3.81M | $5.11M |
| Net income | $1.84M | $3.69M | $1.08M | $2.54M | $3.16M | $4.95M | $1.38M | $3.02M | $2.24M | $11.18M | $2.53M | $2.83M |
Balance Sheet
As of Apr 2026, total debt of $19.77M exceeded cash and equivalents by $9.82M.
Annual
| Line item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $178.31M | $194.65M | $134.77M | $118.90M | $118.77M | $89.38M | $83.93M | $87.22M | $85.08M | $80.92M |
| Current assets | $105.40M | $118.36M | $96.82M | $87.92M | $91.56M | $60.46M | $54.23M | $65.36M | $64.39M | $59.81M |
| Cash and equivalents | $9.95M | $14.94M | $23.27M | $8.08M | $4.43M | $5.21M | $4.37M | $10.65M | $9.72M | $12.51M |
| Total liabilities | $101.50M | $128.41M | $78.56M | $80.41M | $82.59M | $47.90M | $45.23M | $39.52M | $36.89M | $37.66M |
| Short-term debt | $4.97M | $3.89M | $3.10M | $3.59M | $1.59M | $6.83M | $4.72M | $10.68M | $5.05M | $4.51M |
| Long-term debt | $14.80M | $33.95M | $0 | N/A | N/A | N/A | N/A | $97.00K | $1.26M | $2.43M |
| Shareholder equity | $74.72M | $64.46M | $54.76M | $37.41M | $35.69M | $41.24M | $38.41M | $47.10M | $47.73M | $42.88M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $175.80M | $178.31M | $175.96M | $189.07M | $193.49M | $194.65M | $189.15M | $134.48M | $132.02M | $134.77M | $126.31M | $121.71M |
| Total liabilities | $98.58M | $101.50M | $103.43M | $117.36M | $124.62M | $128.41M | $127.03M | $73.82M | $74.50M | $78.56M | $80.96M | $78.29M |
| Cash and equivalents | $8.25M | $11.62M | $8.15M | $12.59M | $19.49M | $14.94M | $9.45M | $25.96M | $24.21M | $25.94M | $21.31M | $13.72M |
| Shareholder equity | $75.00M | $74.72M | $70.67M | $69.85M | $67.08M | $64.46M | $60.80M | $59.33M | $56.02M | $54.76M | $44.08M | $42.11M |
Cash Flow
In the fiscal year ended Apr 2026, free cash flow was 78.9% of operating cash flow. Dividends came to 2.3% of it, with no share repurchases.
Annual
| Line item | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.63M | $14.78M | $19.56M | -$3.79M | -$7.88M | $912.00K | $4.16M | $2.49M | $3.18M | $11.66M |
| Capital expenditures | $3.94M | $2.17M | $4.37M | $4.15M | $1.91M | $2.40M | $2.46M | $4.21M | $3.40M | $2.61M |
| Free cash flow | $14.70M | $12.62M | $15.19M | -$7.94M | -$9.79M | -$1.49M | $1.70M | -$1.72M | -$212.00K | $9.05M |
| Dividends paid | $339.00K | $261.00K | $0 | N/A | N/A | $108.00K | $1.37M | $2.08M | $1.87M | $1.63M |
| Share repurchases | $0 | $1.60M | $2.00M | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$3.94M | -$30.90M | -$4.37M | -$4.15M | -$1.91M | -$2.40M | -$2.46M | -$4.21M | -$3.40M | -$2.48M |
| Financing cash flow | -$19.33M | $7.41M | -$3.01M | $14.93M | $11.03M | $1.98M | -$7.46M | $2.33M | -$2.48M | -$2.08M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.98M | $5.46M | $11.65M | -$4.26M | $5.79M | $9.41M | -$2.27M | $8.44M | -$794.00K | $1.15M | $9.50M | $747.00K |
| Capital expenditures | $772.00K | $928.00K | $668.00K | $1.57M | $771.00K | $516.00K | $689.00K | $683.00K | $278.00K | $979.00K | $475.00K | $1.26M |
| Free cash flow | $1.20M | $4.53M | $10.98M | -$5.83M | $5.02M | $8.89M | -$2.96M | $7.75M | -$1.07M | $166.00K | $9.03M | -$518.00K |
Frequently Asked Questions About KEQU
What is Kewaunee Scientific's annual revenue?
Kewaunee Scientific reported revenue of $282.00M for the fiscal year ended Apr 30, 2026.
How fast is Kewaunee Scientific's revenue growing?
Revenue was up 17.3% for the fiscal year ended Apr 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 8.7%.
Is Kewaunee Scientific profitable?
Yes. Kewaunee Scientific reported net income of $10.46M for the fiscal year ended Apr 30, 2026, with a net margin of 3.7%.
How much free cash flow does KEQU generate?
For the fiscal year ended Apr 30, 2026, operating cash flow of $18.63M minus capital expenditures of $3.94M produced free cash flow of $14.70M.
How much debt does Kewaunee Scientific have?
The balance sheet dated Apr 30, 2026 reported long-term debt of $14.80M, short-term debt of $4.97M and cash and equivalents of $9.95M.
KEQU pages: Overview, Earnings, Financials, Valuation, Competitors